Holen Sie sich die Stockscreener-App
35.78
5.14%
-1.94
Handel nachbörslich:
35.08
-0.70
-1.96%
Finanzdaten der Nektar Therapeutics-Aktie (NKTR)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
6.72%
10.13
|
10.86 | 21.81 | 11.79 | 11.18 |
Research and Development
|
9.67%
39.13
|
35.68 | 29.71 | - | - |
| Costs And Expenses |
5.12%
52.47
|
49.91 | 49.47 | 43.46 | 47.41 |
| Depreciation and Amortization |
3.31%
0.156
|
0.151 | 0.19 | 0.196 | 0.214 |
| Operating Income/Loss |
8.42%
-42.34
|
-39.05 | -27.66 | -31.67 | -36.23 |
| Nonoperating Income/Loss |
150.55%
2.04
|
-4.036 | -7.037 | -3.349 | -3.165 |
| Income/Loss From Equity Method Investments |
81.77%
-0.319
|
-1.75 | -1.346 | -0.534 | -2.386 |
| Income/Loss From Continuing Operations Before Tax |
6.47%
-40.30
|
-43.09 | -34.70 | -35.02 | -39.40 |
| Income Tax Expense/Benefit |
96.88%
0.002
|
0.064 | 0.031 | -0.033 | -0.188 |
| Net Income/Loss |
9.54%
-40.62
|
-44.90 | -36.08 | -35.52 | -41.59 |
| Basic Average Shares |
33.63%
33.05
|
24.74 | - | 18.95 | 14.09 |
| Diluted Average Shares |
33.63%
33.05
|
24.74 | - | 18.95 | 14.09 |
| Basic Earnings Per Share |
32.42%
-1.23
|
-1.82 | - | -1.87 | -2.95 |
| Diluted Earnings Per Share |
32.42%
-1.23
|
-1.82 | - | -1.87 | -2.95 |
6.12%
0.14%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):